Revolution Medicines, Inc. Quarterly Return On Assets in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Revolution Medicines, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q3 2024.
  • Revolution Medicines, Inc. Return On Assets for the quarter ending September 30, 2024 was -30.1 %, a 10.5% increase year-over-year.
  • Revolution Medicines, Inc. annual Return On Assets for 2023 was -33.6 %, a 0.21% increase from 2022.
  • Revolution Medicines, Inc. annual Return On Assets for 2022 was -33.7 %, a 37.7% decline from 2021.
  • Revolution Medicines, Inc. annual Return On Assets for 2021 was -24.5 %, a 17.1% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -30.1 +3.53 +10.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 -30.7 +0.6 +1.92% Apr 1, 2024 Jun 30, 2024
Q1 2024 -32.1 -1.13 -3.65% Jan 1, 2024 Mar 31, 2024
Q4 2023 -33.6 +0.07 +0.21% Oct 1, 2023 Dec 31, 2023
Q3 2023 -33.6 +0.4 +1.18% Jul 1, 2023 Sep 30, 2023
Q2 2023 -31.3 +0.89 +2.76% Apr 1, 2023 Jun 30, 2023
Q1 2023 -31 -2.66 -9.39% Jan 1, 2023 Mar 31, 2023
Q4 2022 -33.7 -9.22 -37.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34 -10.7 -45.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -32.2 -11.4 -54.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -28.3 -7.61 -36.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -24.5 -3.57 -17.1% Oct 1, 2021 Dec 31, 2021
Q3 2021 -23.4 -2.81 -13.7% Jul 1, 2021 Sep 30, 2021
Q2 2021 -20.8 Apr 1, 2021 Jun 30, 2021
Q1 2021 -20.7 Jan 1, 2021 Mar 31, 2021
Q4 2020 -20.9 Oct 1, 2020 Dec 31, 2020
Q3 2020 -20.6 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.